Conatus Pharmaceuticals, Inc.. (CNAT) NASDAQ
$0.56 - (-)
Market Cap: $18.58M
As of 05/26/20 04:00 PM EDT. Market closed.
Conatus Pharmaceuticals, Inc.. (CNAT)
NASDAQ
$0.56
- (-)
Market Cap: $18.58M
As of 05/26/20 04:00 PM EDT. Market closed.
Add to Portfolio
Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active ... read more
COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO
Steven J. Mento
Full Time Employees
6
CEO Compensation (Base)
$521,433
CEO Compensation (Total)
$1.30M
Sector
Health Technology
Industry
Biotechnology
CEO
Steven J. Mento
Full Time Employees
6
CEO Compensation (Base)
$521,433
CEO Compensation (Total)
$1.30M
Address
16745 West Bernardo Drive, CA, San Diego, 92127-7619.
PRICE CHART FOR CONATUS PHARMACEUTICALS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
$0.23 - $1.07
Volume
0
Avg. Volume (30 days)
2,531,496
Market Cap
$18.58M
Dividend Yield
-
P/E
-
Shares Outstanding
33,170,000
Open
-
Previous Close
-
Days Range
- - -
52 week range
$0.23 - $1.07
Volume
0
Avg. Volume (30 days)
2,531,496
Market Cap
$18.58M
Dividend Yield
-
P/E
-
Shares Outstanding
33,170,000
FINANCIAL STATEMENTS FOR CONATUS PHARMACEUTICALS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CONATUS PHARMACEUTICALS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Pascoe Richard W | President, CEO & Director | Mar 30, 2021 | Buy | $1.14 | 20,000 | 22,800 | 30,000 | Mar 30, 2021, 06:28 PM |
| Pascoe Richard W | President, CEO & Director | Dec 03, 2020 | Buy | $1.24 | 10,000 | 12,394 | 10,000 | Dec 07, 2020, 04:06 PM |
| Marshall Keith W | EVP, COO & CFO | May 22, 2020 | Option Exercise | $0.56 | 18,615 | 10,424 | 19,885 | May 27, 2020, 06:09 AM |
| Spada Alfred P. | EVP, R&D and CSO | May 22, 2020 | Option Exercise | $0.56 | 12,960 | 7,258 | 19,595 | May 27, 2020, 06:05 AM |
| Mento Steven J | Director | May 22, 2020 | Option Exercise | $0.56 | 31,428 | 17,600 | 39,572 | May 27, 2020, 06:04 AM |
| Smith Edward F III | SVP, Reg Affairs and QA | May 14, 2018 | Option Exercise | $3.31 | 4,690 | 15,524 | 9,151 | Feb 11, 2019, 04:20 PM |
| Smith Edward F III | SVP, Reg Affairs and QA | Nov 14, 2018 | Option Exercise | $3.15 | 1,724 | 5,431 | 10,875 | Feb 11, 2019, 04:20 PM |
| RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | Nov 14, 2018 | Option Exercise | $3.15 | 1,861 | 5,862 | 32,431 | Feb 11, 2019, 04:19 PM |
| RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | May 14, 2018 | Option Exercise | $3.31 | 1,290 | 4,270 | 30,570 | Feb 11, 2019, 04:19 PM |
| Mento Steven J | President, CEO & Director | May 04, 2018 | Option Exercise | $0.99 | 60,000 | 59,400 | 60,000 | May 07, 2018, 07:46 PM |
| Spada Alfred P. | EVP, R&D and CSO | Feb 27, 2018 | Option Exercise | $1.24 | 12,121 | 15,030 | 12,121 | Mar 01, 2018, 04:08 PM |
| Smith Edward F III | SVP, Reg Affairs and QA | Nov 14, 2017 | Option Exercise | $3.48 | 4,461 | 15,524 | 4,461 | Feb 05, 2018, 05:03 PM |
| RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | Nov 14, 2017 | Option Exercise | $3.48 | 818 | 2,847 | 29,280 | Feb 05, 2018, 05:02 PM |
| RIPLEY DANIEL L. | SVP, Bus Dev, P&A Mgmt | May 12, 2017 | Option Exercise | $1.70 | 761 | 1,294 | 28,462 | Feb 05, 2018, 05:02 PM |
| Cashion Charles | SVP, Finance, CFO and Sec. | Jan 09, 2017 | Option Exercise | $0.99 | 42,424 | 42,000 | 42,424 | Jan 11, 2017, 04:01 PM |
| Mento Steven J | President, CEO & Director | Dec 20, 2016 | Option Exercise | $1.21 | 41,414 | 50,091 | 41,414 | Dec 22, 2016, 04:04 PM |
| Van Wart Harold | Director | Oct 27, 2016 | Option Exercise | $0.25 | 18,181 | 4,545 | 18,181 | Oct 31, 2016, 04:37 PM |
| KISNER DANIEL L | Director | Apr 08, 2015 | Buy | $5.75 | 4,000 | 23,000 | 7,145 | Apr 10, 2015, 04:02 PM |
| HALE DAVID F | Director | Jan 08, 2014 | Option Exercise | $0.99 | 12,121 | 12,000 | 24,242 | Jan 10, 2014, 05:07 PM |
| HALE DAVID F | Director | Sep 26, 2013 | Option Exercise | $2.31 | 12,121 | 28,000 | 12,121 | Sep 27, 2013, 04:29 PM |
| Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 251 | 2,761 | 49,949 | Aug 01, 2013, 07:18 PM |
| Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 10,614 | 116,754 | 2,121,992 | Aug 01, 2013, 07:18 PM |
| Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Buy | $11.00 | 104,952 | 1,154,472 | 2,226,944 | Aug 01, 2013, 07:18 PM |
| Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Buy | $11.00 | 2,470 | 27,170 | 52,419 | Aug 01, 2013, 07:18 PM |
| Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Sale | $11.00 | 14 | 154 | 49,698 | Aug 01, 2013, 07:18 PM |
| Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Sale | $11.00 | 552 | 6,072 | 2,111,378 | Aug 01, 2013, 07:18 PM |
| Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Option Exercise | $0.08 | 1,727 | 142 | 49,712 | Aug 01, 2013, 07:18 PM |
| Aberdare GP III, L.L.C. | 10% Owner | Jul 30, 2013 | Option Exercise | $0.08 | 73,395 | 6,055 | 2,111,930 | Aug 01, 2013, 07:18 PM |
| Perret Marc Olivier | Director | Jul 30, 2013 | Option Exercise | $11.00 | 16,742 | 184,162 | 1,321,795 | Aug 01, 2013, 07:18 PM |
| Perret Marc Olivier | Director | Jul 30, 2013 | Buy | $11.00 | 165,525 | 1,820,775 | 1,487,320 | Aug 01, 2013, 07:18 PM |
| Perret Marc Olivier | Director | Jul 30, 2013 | Sale | $11.00 | 352 | 3,872 | 1,305,053 | Aug 01, 2013, 07:18 PM |
| Mento Steven J | President, CEO & Director | Jul 30, 2013 | Option Exercise | $11.00 | 1,395 | 15,345 | 371,869 | Aug 01, 2013, 07:16 PM |
| Mento Steven J | President, CEO & Director | Jul 30, 2013 | Buy | $11.00 | 13,800 | 151,800 | 385,669 | Aug 01, 2013, 07:16 PM |
| KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Option Exercise | $11.00 | 10,614 | 116,754 | 2,121,992 | Aug 01, 2013, 07:16 PM |
| KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Option Exercise | $11.00 | 251 | 2,761 | 49,949 | Aug 01, 2013, 07:16 PM |
| KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Buy | $11.00 | 104,952 | 1,154,472 | 2,226,944 | Aug 01, 2013, 07:16 PM |
| KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Buy | $11.00 | 2,470 | 27,170 | 52,419 | Aug 01, 2013, 07:16 PM |
| KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Sale | $11.00 | 552 | 6,072 | 2,111,378 | Aug 01, 2013, 07:16 PM |
| KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Sale | $11.00 | 14 | 154 | 49,698 | Aug 01, 2013, 07:16 PM |
| KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Option Exercise | $0.08 | 1,727 | 142 | 49,712 | Aug 01, 2013, 07:16 PM |
| KLINGENSTEIN PAUL H | Director | Jul 30, 2013 | Option Exercise | $0.08 | 73,395 | 6,055 | 2,111,930 | Aug 01, 2013, 07:16 PM |
| Malik Shahzad | Director | Jul 30, 2013 | Option Exercise | $11.00 | 19,223 | 211,453 | 1,976,782 | Aug 01, 2013, 07:14 PM |
| Malik Shahzad | Director | Jul 30, 2013 | Buy | $11.00 | 190,054 | 2,090,594 | 2,166,836 | Aug 01, 2013, 07:14 PM |
| Malik Shahzad | Director | Jul 30, 2013 | Sale | $11.00 | 535 | 5,885 | 1,957,559 | Aug 01, 2013, 07:14 PM |
| Malik Shahzad | Director | Jul 30, 2013 | Option Exercise | $0.08 | 70,003 | 5,775 | 1,958,094 | Aug 01, 2013, 07:14 PM |
| LACASSE LOUIS P | Director | Jul 30, 2013 | Option Exercise | $11.00 | 12,537 | 137,907 | 685,937 | Aug 01, 2013, 07:12 PM |
| LACASSE LOUIS P | Director | Jul 30, 2013 | Buy | $11.00 | 123,950 | 1,363,450 | 809,887 | Aug 01, 2013, 07:12 PM |
| HALE DAVID F | Director | Jul 30, 2013 | Option Exercise | $11.00 | 261 | 2,871 | 141,151 | Aug 01, 2013, 07:11 PM |
| HALE DAVID F | Director | Jul 30, 2013 | Buy | $11.00 | 2,588 | 28,468 | 143,739 | Aug 01, 2013, 07:11 PM |
| COOPERATIVE GILDE HEALTHCARE II U.A. | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 16,742 | 184,162 | 1,321,795 | Aug 01, 2013, 07:10 PM |
| COOPERATIVE GILDE HEALTHCARE II U.A. | 10% Owner | Jul 30, 2013 | Buy | $11.00 | 165,525 | 1,820,775 | 1,487,320 | Aug 01, 2013, 07:10 PM |
| COOPERATIVE GILDE HEALTHCARE II U.A. | 10% Owner | Jul 30, 2013 | Sale | $11.00 | 352 | 3,872 | 1,305,053 | Aug 01, 2013, 07:10 PM |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 19,223 | 211,453 | 1,976,782 | Aug 01, 2013, 07:09 PM |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | Jul 30, 2013 | Buy | $11.00 | 190,054 | 2,090,594 | 2,166,836 | Aug 01, 2013, 07:09 PM |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | Jul 30, 2013 | Sale | $11.00 | 535 | 5,885 | 1,957,559 | Aug 01, 2013, 07:09 PM |
| ADVENT VENTURE PARTNERS LLP | 10% Owner | Jul 30, 2013 | Option Exercise | $0.08 | 70,003 | 5,775 | 1,958,094 | Aug 01, 2013, 07:09 PM |
| Scopa James Paul | Director | Jul 30, 2013 | Option Exercise | $11.00 | 16,716 | 183,876 | 1,026,815 | Aug 01, 2013, 02:21 PM |
| Scopa James Paul | Director | Jul 30, 2013 | Buy | $11.00 | 165,265 | 1,817,915 | 1,192,080 | Aug 01, 2013, 02:21 PM |
| EVNIN LUKE | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 16,716 | 183,876 | 1,026,815 | Aug 01, 2013, 02:19 PM |
| EVNIN LUKE | 10% Owner | Jul 30, 2013 | Buy | $11.00 | 165,265 | 1,817,915 | 1,192,080 | Aug 01, 2013, 02:19 PM |
| MPM BioVentures IV QP LP | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 16,716 | 183,876 | 1,026,815 | Aug 01, 2013, 02:18 PM |
| MPM BioVentures IV QP LP | 10% Owner | Jul 30, 2013 | Buy | $11.00 | 165,265 | 1,817,915 | 1,192,080 | Aug 01, 2013, 02:18 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR CONATUS PHARMACEUTICALS, INC.
STOCK BUYBACKS FOR CONATUS PHARMACEUTICALS, INC.
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
0%
1Q
09/30/2022
20.17%
3Q
BUYBACK ANNOUNCEMENT(S) FOR CONATUS PHARMACEUTICALS, INC.
LOADING...